Primary Record
nalidixic acid
- In stock
- 4,165 g
- Purity
- 99.6 %
- CAS
- 389-08-2
Compound Identifiers & Properties
- CAS
- 389-08-2
- PubChem CID
- 4421
- SMILES
- CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O
- Canonical SMILES
- CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21
Names & Synonyms
- nalidixic acid
- Nalidixin
- Nalidixate
- Nevigramon
- NegGram
- Nalidixan
- Uronidix
- Nalitucsan
- Wintomylon
- Innoxalon
- Nalidic acid
- Unaserus
- Dixiben
- Nalurin
- Naxuril
- Nogram
- Urisal
- Nalidixinic acid
- Nalix
- Sicmylon
- Cybis
- Betaxina
- Specifin
- Urodixin
- Dixinal
- Jicsron
- Uralgin
- Uriclar
- Negram
- Uriben
- Uroman
- Uroneg
- 389-08-2
- Nalidicron
- Kusnarin
- Nicelate
- Narigix
- Poleon
- Uropan
- Acide nalidixique
- Acido nalidixico
- Specifen
- Naldixic acid
- Acide nalidixico
- Eucistin
- Acidum nalidixicum
- Nalidixane
- Wintron
- naladixic acid
- Eucisten
- Nalidixic
- Acido nalidissico
- Nacid
- Acid, Nalidixic
- Innoxalomn
- Novigramon
- Takesimylon
- Wintorin
- Youdix
- nalidixic-acid
- Nalidixanum;
- Wintomylon;
- Negram;
- Sodium,Nalidixate
- Neg Gram
- Cybis;
- NegGram (TN)
- Wintomylon (TN)
- Acido nalidissico [DCIT]
- Nalidixic Acid-d5
- NSC-82174
- Acide nalidixico [Italian]
- Acide nalidixique [French]
- Nalidixic acid USP27
- WIN 18,320
- NALIDIXICACID
- NALIDIXATE SODIUM
- Nalidixic acid sodium
- 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- NCI-C56199
- CHEMBL5
- Nalidixic acid (NegGram)
- MFCD00006884
- Nalidixic acid sodium salt
- Spectrum_000918
- Win 18320
- Acide nalidixique [INN-French]
- Acido nalidixico [INN-Spanish]
- Acidum nalidixicum [INN-Latin]
- RefChem:55688
- Maybridge1_007101
- Opera_ID_1064
- Prestwick0_000187
- Prestwick1_000187
- Prestwick2_000187
- Prestwick3_000187
- Spectrum2_001360
- Spectrum3_000075
- Spectrum4_000817
- Spectrum5_001540
- 3B91HWA56M
- CCRIS 2365
- UNII-3B91HWA56M
- C12H12N2O3
- Nalidixic acid (Standard)
- DTXSID3020912
- WIN-18320
- D07JGT
- DTXCID70912
- Epitope ID:613449
- Nalidixic acid, >=98%
- UPCMLD-DP129
- HSDB 3241
- AC1L1I4P
- MLS000028504
- 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
- CHEBI:100147
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N
- wil 18,320
- Anhydrous, Nalidixate Sodium
- NALIDIXIC ACID [MI]
- NCIOpen2_004342
- Lopac0_000837
- Oprea1_010545
- SCHEMBL21736
- BSPBio_000113
- BSPBio_001889
- KBioGR_001333
- KBioSS_001398
- NALIDIXIC ACID [INN]
- NALIDIXIC ACID [JAN]
- MLS001148578
- MLS002303041
- MLS004820190
- MLS006011875
- NSC82174
- 1-ethyl-7-methyl-4-oxo-1
- BIDD:GT0529
- DivK1c_000058
- NALIDIXIC ACID [HSDB]
- NALIDIXIC ACID [USAN]
- Sodium Nalidixic Acid, Anhydrous
- SPECTRUM1500756
- EINECS 206-864-7
- SPBio_001579
- SPBio_002034
- 3-Carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one
- NALIDIXIC ACID [VANDF]
- 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
- AC1Q310A
- BPBio1_000125
- orb1710668
- orb3025294
- Sodium Nalidixic Acid, Monohydrate
- NALIDIXIC ACID [MART.]
- Nalidixic acid [USAN:INN:BAN:JAN]
- NALIDIXIC ACID [WHO-DD]
- SCHEMBL29367723
- UPCMLD-DP129:001
- 3-Carboxy-1-ethyl-7-methyl-1,8-naphthidin-4-one
- BDBM21691
- CTK1C2660
- ERK5-2I20
- GTPL12773
- HMS500C20
- HMS561K17
- HY-B0398R
- KBio1_000058
- KBio2_001398
- KBio2_003966
- KBio2_006534
- KBio3_001109
- KS-00000XTB
- ZERO/002632
- ZINC57421
- BRN 0750515
- CID4421
- J01MB02
- MSK5735
- NINDS_000058
- HMS1921G10
- HMS2092K04
- HMS2232H24
- HMS3259O13
- HMS3374G11
- HMS3656K05
- HMS5080P10
- LS-72
- Pharmakon1600-01500756
- Nalidixic acid (JP15/USP/INN)
- Nalidixic acid (JP18/USP/INN)
- Nalidixic acid, analytical standard
- WIN 183203
- ALBB-021275
- HY-B0398
- MSK5735-1000DM
- Tox21_110835
- Tox21_201477
- Tox21_302754
- WIN-18320 (TN)
- 1,8-naphthyridine-3-carboxylic Acid
- ANW-42195
- BBF-04485
- BBL012279
- CCG-39298
- EBC-04219
- MSK5735-100M
- NALIDIXIC ACID [EP IMPURITY]
- NALIDIXIC ACID [ORANGE BOOK]
- NCGC00018181-08
- NegGram;Nevigramon;Nalidixin;Uronidix
- NSC757432
- SBB002146
- STK735579
- NALIDIXIC ACID [USP IMPURITY]
- SMR000058264
- 1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-
- 1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure
- AKOS000120074
- C12-H12-N2-O3
- Tox21_110835_1
- AN16320
- CS-2493
- CS-O-02000
- DB00779
- J2.039G
- Nalidixic acid [USAN:USP:INN:BAN:JAN]
- NC00494
- NSC-757432
- RTR-015647
- SDCCGSBI-0050814.P004
- 1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid
- IDI1_000058
- Nalidixic acid, 99% - 100G 100g
- NCGC00018181-01
- NCGC00018181-02
- NCGC00018181-03
- NCGC00018181-04
- NCGC00018181-05
- NCGC00018181-06
- NCGC00018181-07
- NCGC00018181-09
- NCGC00018181-10
- NCGC00018181-12
- NCGC00018181-13
- NCGC00021730-03
- NCGC00021730-04
- NCGC00021730-05
- NCGC00021730-06
- NCGC00021730-07
- NCGC00256581-01
- NCGC00259028-01
- Acide 1-etil-7-metil-1,8-naftiridin-4-one-3-carbossilico
- AK163550
- AN-23434
- AS-13289
- CAS-389-08-2
- CPD000058264
- H816
- Nalidixic acid 100 microg/mL in Acetonitrile
- NCI60_041807
- SAM002554914
- SC-18641
- SMR004703506
- SY049448
- WLN: T66 BN EV JNJ B2 DVQ I1
- Nalidixic acid 100 microg/mL in Methanol
- SBI-0050814.P003
- AB0013282
- AB2000553
- DB-049349
- Nalidixic acid 1000 microg/mL in Methanol
- TR-015647
- 1, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-
- B1985
- BB 0242389
- FT-0603390
- N0490
- NS00009829
- S2328
- SW219624-1
- 1-Ethyl-1,8-naphthyridine-3-carboxilic acid
- 1-Ethyl-1,8-naphthyridine-3-carboxylic acid
- 5-25-07-00384 (Beilstein Handbook Reference)
- EN300-20573
- VU0239598-6
- 1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure [German]
- C05079
- D00183
- D91720
- K-8443
- N-1200
- Nalidixic acid Solution in Methanol, 100ug/mL
- Acide 1-etil-7-metil-1,8-naftiridin-4-one-3-carbossilico [Italian]
- Nalidixic acid, meets USP testing specifications
- 1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-
- 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
- 389N082
- A947778
- F358268
- Q281082
- SR-01000003086
- SR-01000003086-4
- SR-01000003086-6
- 1,4-Dihydro-1-ethyl-7-methyl-1,8-naphthyridin-4-one-3-carboxylic acid
- BRD-K47886988-001-21-4
- BRD-K47886988-001-22-2
- BRD-K47886988-323-03-0
- I14-18919
- Nalidixic acid Solution in DMSO/Methanol, 1000ug/mL
- SR-01000003086-10
- F0850-6751
- Z104478940
- 1-Ethyl-7-methyl-1,8-naphthyridin-4-one-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylicacid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-
- 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxilic acid
- 1-ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-ca rboxylic acid
- 1-ethyl-7-methyl-4-oxo-[1,8]naphthyridine-3-carboxylic acid
- Nalidixic acid, European Pharmacopoeia (EP) Reference Standard
- 1-Ethyl-7-methyl-4(1H)-oxo-1,8-naphthyridine-3-carboxylic acid
- Nalidixic acid, United States Pharmacopeia (USP) Reference Standard
- 1-Ethyl-1,4-dihydro-4-oxo-7-methyl-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-4-oxo-7-methyl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
- 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylic acid
- 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naph thyridine-3-carboxylic acid
- 1-ethyl-7-methyl-4-oxohydropyridino[2,3-b]pyridine-3-carboxylic acid
- 389-08-2, 3374-05-8 [anhydrous], 15769-77-4 [nalidixate sodium]
- 1-ETHYL-7-METHYL-4-OXO-1,4-DIHYDRO[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID
- 1189467-36-4
- 206-864-7
- InChI=1/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17
- Nalidixic acid; 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid; 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1-Ethyl-7-methyl-1,8-naphthyridin-4-one-3-carboxylic acid; 1-Ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid; 3-Carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one; Betaxina; Cybis; Dixiben; Eucistin; Innoxalomn; NSC 82174; Nacid; Nalidic acid; Nalidicron; Nalidixan; Nalidixic acid; Nalidixin; Nalidixinic acid; Nalitucsan; Nalix; Nalurin; Narigix; Naxuril; NegGram; Nelidix; Nevigramon; Nicelate; Nogram; Poleon; Specifin; Uralgin; Uriben; Uriclar; Urisal; Urodixin; Uroman; Uroneg; Uropan; Win 18320; Wintomylon
- NIX